CD4 and tuberculosis: Previous analysis of clinical trial data from the SECONDLINE study 4, which enrolled participants from sites across Africa, Asia, and South America, identified that the routine laboratory markers, cholesterol and platelets, together with CD4+ cell counts, were inversely associated with the risk of incident TB in PLHIV receiving second-line antiretrovial (ART) treatment 5.